- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03145428
Evaluation of Monocyte Volume Distribution Width (MDW) for Early Detection of Sepsis (MDW)
November 21, 2019 updated by: Beckman Coulter, Inc.
Evaluation of Monocyte Volume Width Distribution (MDW) for Early Detection of Sepsis or Developing Sepsis on the UniCell DxH800 Hematology Analyzer
The measurement of monocyte volume width distribution (MDW) is intended for use with adult patients presenting to the emergency department (ED), where a CBC with Differential has been ordered, as an aid in the early detection of patients with or developing sepsis.
The study will establish the clinical performance of MDW for detection of sepsis in the ED.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A prospective multi-center study to establish the clinical utility of the measurement of monocyte volume width distribution, a cell population parameter of the CBC-Differential, on the Beckman Coulter Unicel DxH analyzers.
The study will validate the cut-off for the early detection of sepsis in an adult emergency room population where the standard of care included a CBC with Differential and will evaluate the diagnostic performance of the parameter.
Study Type
Observational
Enrollment (Actual)
3000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- Hackensack University Medical Center
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- University of Pittsburgh Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All adult patients with suspicion who present to ED and for whom CBC with Diff is performed upon ED presentation.
Description
Inclusion Criteria:
- Adults (18-89 years) presenting to ED
- All races & ethnicities
- CBC with Differential performed upon presentation
- Subjects with at least 12 hours of follow-up in ED (or in-patient if admitted)
Exclusion Criteria:
- Previously enrolled
- Subjects discharged <12 hours form ED presentation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of sepsis vs. non-sepsis, including SIRS and infection (non-SIRS) by adjudication based on the 2001 SCCM sepsis definition (sepsis-2)
Time Frame: 12 hours after presentation to the ED
|
Determination of the diagnostic accuracy, area under the receiver operating characteristic curve
|
12 hours after presentation to the ED
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 19, 2017
Primary Completion (Actual)
December 22, 2017
Study Completion (Actual)
January 26, 2018
Study Registration Dates
First Submitted
May 4, 2017
First Submitted That Met QC Criteria
May 5, 2017
First Posted (Actual)
May 9, 2017
Study Record Updates
Last Update Posted (Actual)
November 22, 2019
Last Update Submitted That Met QC Criteria
November 21, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C03747
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sepsis
-
University of California, San FranciscoNational Cancer Institute (NCI)RecruitingSepsis | Sepsis, Severe | Sepsis and Septic Shock | Sepsis at Intensive Care Unit | Sepsis, Septic Shock | Sepsis, Severe Sepsis and Septic Shock | Sepsis With Multiple Organ Dysfunction (MOD) | Sepsis With Acute Organ DysfunctionUnited States
-
Assiut UniversityNot yet recruitingSepsis Induced Myocardial Dysfunction | Sepsis Induced CardiomyopathyEgypt
-
University of Kansas Medical CenterUniversity of KansasRecruitingSepsis | Septic Shock | Sepsis Syndrome | Sepsis, Severe | Sepsis Bacterial | Sepsis BacteremiaUnited States
-
Jip GroenInBiomeRecruitingMicrobial Colonization | Neonatal Infection | Neonatal Sepsis, Early-Onset | Microbial Disease | Clinical Sepsis | Culture Negative Neonatal Sepsis | Neonatal Sepsis, Late-Onset | Culture Positive Neonatal SepsisNetherlands
-
The University of QueenslandRoyal Brisbane and Women's HospitalUnknown
-
Karolinska InstitutetÖrebro University, SwedenCompletedSepsis | Sepsis Syndrome | Sepsis, SevereSweden
-
Ohio State UniversityCompletedSepsis, Severe Sepsis and Septic ShockUnited States
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
University of LeicesterUniversity Hospitals, Leicester; The Royal College of AnaesthetistsCompletedSepsis | Septic Shock | Severe Sepsis | Sepsis SyndromeUnited Kingdom
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
Clinical Trials on CBC-Diff Monocyte volume width distribution (MDW)
-
Beckman Coulter, Inc.CompletedSepsis | Severe Sepsis | Emergency Department | Adult DiseaseUnited States
-
Beckman Coulter, Inc.CompletedSepsis | Severe Sepsis | Emergency Department | Adult DiseaseUnited States
-
Beckman Coulter, Inc.CompletedSepsis | Severe Sepsis | Emergency Department | Adult DiseaseUnited States
-
Beckman Coulter, Inc.CompletedSepsis | Covid19 | Emergency Department | AdultsUnited States
-
Beckman Coulter, Inc.CompletedSepsis | Severe Sepsis | Emergency Department | Adult DiseaseUnited States
-
Shanghai Public Health Clinical CenterRecruiting
-
Henry Ford Health SystemBeckman Coulter, Inc.Active, not recruitingSepsis | Septic Shock | Bacteremia | Severe Sepsis | Emergency Departments | Continuity of Patient Care | Bacteremia SepsisUnited States
-
Beckman Coulter, Inc.CompletedSepsis | Severe Sepsis | Severe InfectionFrance, Spain
-
Hôpital Universitaire SahloulCompleted
-
Chang Gung Memorial HospitalUnknownSepsis | Diagnoses DiseaseTaiwan